Medicare Advantage shifts from growth strategy to capital allocation decision

Medicare Advantage (MA) plans are no longer a guaranteed path to growth for healthcare systems, according to a new study by Alvarez & Marsal. The "MA Pulse Survey," which gathered insights from 30 senior health system executives, indicates that broad participation in MA plans, once a strategy to protect volume and market share, is now eroding stability.

The report highlights that declining reimbursements, rising utilization, increased claim denials, and administrative friction have fundamentally altered the economics of MA participation. Consequently, MA has evolved from a growth strategy into a strategic capital allocation and operating model decision. Health system leaders must now determine where and how to participate in MA, rather than simply seeking to manage existing arrangements more effectively.

The survey identified five key structural pressure points reshaping MA participation: declining reimbursement rates, operational strain from denials and payment delays, increasing financial pressure on patients, escalating authorization and appeals burdens, and unfavorable utilization trends. These combined factors indicate that the traditional model of widespread MA engagement is diminishing margins and consuming operational capacity.

Successful health systems are moving away from volume-based strategies towards disciplined, data-driven partnerships. They are pruning low-yield contracts, concentrating on economically defensible arrangements, and redeploying resources. This shift towards intentional portfolio design, rather than reactive optimization, is presented as crucial for restoring financial control and achieving sustainable growth.